ESMO Policy News
The World Health Organization Releases Guide to Update National Essential Medicines Lists
WHO Guide ‘Selection of Essential Medicines at Country Level: Using the WHO Model List of Essential Medicines to update a national essential medicines list’
Biosimilars have a fascinating story of development and understanding it is crucial for widespread adoption
Biosimilars have a fascinating story of development, says Rosa Giuliani, and understanding it is crucial for widespread adoption.
ESMO and ASCO call on governments to improve cancer services and reduce cancer deaths
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), the world’s two leading organisations for oncology professionals, today issued a joint statement calling upon governments to renew political commitment to improve cancer services and reduce cancer deaths.
ESMO Emphasises Importance of Cancer on the Global Health Agenda at the 71st World Health Assembly
At the 71st World Health Assembly (WHA) in Geneva, Switzerland, ESMO, the leading professional organisation for medical oncology, delivered two statements positioning cancer as a priority on the World Health Organisation’s (WHO) global agenda.
Global Cancer Control: Responding to the Growing Burden, Rising Costs and Inequalities in Access
Policy recommendations and concrete actions governments can take towards achieving the goals of the landmark World Health Assembly Resolution on ‘Cancer prevention and control within an integrated approach’ adopted unanimously by the 194 WHO Member States in May 2017.
ESMO - EIU Report on Shortages of Inexpensive, Essential Cancer Medicines
Launch Event: 17 May 2017 at the European Parliament